Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SILENCE-NEUROMA Trial: Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection in a Randomized Controlled Trial

NCT07431944 is registered in ClinicalTrials.gov with Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) as lead sponsor.

NCT NCT07431944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07431944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SILENCE-NEUROMA Trial: Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection in a Randomized Controlled Trial
Lead sponsor
Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 15, 2026
Completion date
December 15, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, pain management, phantom limb pain, phantom limb pain after amputation